PTGS2 and cancer: Unfortunately, NSAIDs seem to exercise their anti-cancer adjuvant effects only through the inhibition of the inducible COX-2, whereas unwanted side effects, such as gastrointestinal problems, are thought to arise from the inhibition of the constitutive COX-1 [21,22,23].